Rheumatoid Arthritis Clinical Trials in Houston

Showing 181-200 of 1,660 trials

Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome

NCT04160052

This phase I/II trial studies the side effects and best dose of venetoclax when given together with azacitidine in treating patients with high-risk myelodysplastic syndrome that has come back (recurrent) or does not respond to treatment (refractory). Drugs used in chemotherapy, such as venetoclax and azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Myelodysplastic Syndrome+2 more

M.D. Anderson Cancer Center51 participantsStarted Oct 2019

Houston, Texas, United States

COMPLETEDPHASE2/PHASE3< 1 mile

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

NCT04767373

The primary objectives of this phase 2b/3 double-blind, randomized, placebo-controlled study are to evaluate the efficacy and safety of clesrovimab in healthy pre-term and full-term infants. It is hypothesized that clesrovimab will reduce the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infection (MALRI) from Days 1 through 150 postdose compared to placebo.

Respiratory Syncytial Virus Infection

Merck Sharp & Dohme LLC3,632 participantsStarted Apr 2021

Dothan, Alabama, United States • Fayetteville, Arkansas, United States • Jonesboro, Arkansas, United States +214 more locations

Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Rheumatoid Arthritis Trials in Other Cities

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Maternal-fetal Immune Responses to Fetal Surgery

Randomized Clinical Trial for Ewing Amputation in the VA

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

A Study of AZD0120 in Autoimmune Diseases

Intermuscular Coherence as a Biomarker for ALS

Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Other Conditions in Houston